These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1127 related articles for article (PubMed ID: 821894)

  • 1. Effects of 5-bromodeoxyuridine on tumorigenicity, immunogenicity, virus production, plasminogen activator, and melanogenesis of mouse melanoma cells.
    Silagi S
    Int Rev Cytol; 1976; 45():65-111. PubMed ID: 821894
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of melanoma cell tyrosinase activity and tumorigenicity after incorporation of bromouracil for one or two cell divisions.
    Wrathall JR; Newcomb EW; Balint R; Zeitz L; Silagi S
    J Cell Physiol; 1975 Dec; 86 Suppl 2(3 Pt 2):581-92. PubMed ID: 811676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects on growth and tumorigenicity of mouse melanoma cells by thymidine and its analogs, 5-ethyl- and 5-bromodeoxyuridine.
    Silagi S; Balint RF; Gauri KK
    Cancer Res; 1977 Sep; 37(9):3367-73. PubMed ID: 884681
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship of antigenicity of melanoma cells grown in 5-bromodeoxyuridine to reduced tumorigenicity.
    Silagi S; Newcomb EW; Weksler ME
    Cancer Res; 1974 Jan; 34(1):100-4. PubMed ID: 4358536
    [No Abstract]   [Full Text] [Related]  

  • 5. Control of phenotypic expression of cultured melanoma cells by melanocyte stimulating hormones.
    Wong G; Pawelek J
    Nat New Biol; 1973 Feb; 241(111):213-5. PubMed ID: 4349438
    [No Abstract]   [Full Text] [Related]  

  • 6. Two types of melanogenesis in monolayer cultures of melanoma cells.
    Oikawa A; Nakayasu M; Claunch C; Tchen TT
    Cell Differ; 1972 Aug; 1(3):149-55. PubMed ID: 4209534
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the control of differentiation of murine virus-induced erythroleukemic cells.
    Friend C; Preisler HD; Scher W
    Curr Top Dev Biol; 1974; 8():81-101. PubMed ID: 4133033
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors regulating growth and pigmentation of melanoma cells.
    Pawelek JM
    J Invest Dermatol; 1976 Apr; 66(4):201-9. PubMed ID: 178804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible suppression of malignancy and differentiation of melanoma cells.
    Silagi S
    Am J Pathol; 1977 Dec; 89(3):671-84. PubMed ID: 596422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of SV40 T antigen in transformed hamster cells by chronic treatment with 5-bromo-2-deoxyuridine.
    Kreider JW; Del Villano B; Shoff WH; Davidson EA
    Cancer Res; 1972 Oct; 32(10):2148-55. PubMed ID: 4343009
    [No Abstract]   [Full Text] [Related]  

  • 11. Ultrastructural effects of thymidine analogs in melanosomes and virus activation in cloned hamster melanoma cells in culture.
    Epstein WL; Fukuyama K; Drake TE
    Yale J Biol Med; 1973 Dec; 46(5):471-81. PubMed ID: 4798393
    [No Abstract]   [Full Text] [Related]  

  • 12. The ultrastructure of melanoma cells treated with 5-bromodeoxyuridine.
    Endo H; Hu F
    J Invest Dermatol; 1974 Jun; 62(6):603-10. PubMed ID: 4209149
    [No Abstract]   [Full Text] [Related]  

  • 13. Dissociation of plasminogen activator from the transformed phenotype in a 5-bromodeoxyuridine dependent mutant of Syrian hamster melanoma cells.
    Rosenthal SL; Zucker D; Davidson RL
    J Cell Physiol; 1978 Jun; 95(3):275-85. PubMed ID: 649664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlated suppression by 5-bromodeoxyuridine of tumorigenicity and plasminogen activator in mouse melanoma cells.
    Christman JK; Silagi S; Newcomb EW; Silverstein SC; Acs G
    Proc Natl Acad Sci U S A; 1975 Jan; 72(1):47-50. PubMed ID: 123336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of pigmentation in mouse melanoma cells by 5-bromodeoxyuridine: effects on tyrosinase activity and melanosome formation.
    Wrathall JR; Oliver C; Silagi S; Essner E
    J Cell Biol; 1973 May; 57(2):406-23. PubMed ID: 4633171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific protein production during melanogenesis in B16/C3 melanoma cells.
    Laskin JD; Piccinini L; Engelhardt DL; Weinstein IB
    J Cell Physiol; 1983 Jan; 114(1):68-72. PubMed ID: 6826662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone effect on the growth rate, the plasminogen activator, and the MMTV RNA dependent DNA polymerase in a mouse mammary tumor cell line.
    Failly-Crèpin C; Fromont S; Crèpin M
    Biochem Biophys Res Commun; 1981 Sep; 102(1):22-9. PubMed ID: 6171281
    [No Abstract]   [Full Text] [Related]  

  • 18. Tyrosinase activities of cell-free extracts and living cells of cultured melanoma cells.
    Oikawa A; Nakayasu M; Nohara M
    Dev Biol; 1973 Jan; 30(1):198-205. PubMed ID: 4633285
    [No Abstract]   [Full Text] [Related]  

  • 19. 5-Bromodeoxyuridine-tolerant melanoma cells in vitro and in vivo.
    Pasztor LM; Hu F; McNulty WP
    Yale J Biol Med; 1973 Dec; 46(5):397-410. PubMed ID: 4544338
    [No Abstract]   [Full Text] [Related]  

  • 20. Co-cultivation of tumorigenic mouse melanoma cells with cells of a non-tumorigenic subclone inhibits plasminogen activator expression by the melanoma cells.
    Kyner D; Christman J; Acs G; Silagi S; Newcomb EW; Silverstein SC
    J Cell Physiol; 1978 May; 95(2):159-67. PubMed ID: 206566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.